Cell Biology International Reports · 1988 · 34 citations · 7 references
MedicinePathobiologyPathologyDiabetologyGastroenterologyDiabetes MellitusGastric DiseasesGastric DisordersGastrointestinal DiseaseGastrointestinal PathologyGastrointestinal PathophysiologyAcute Gastric Mucosal LesionsGastric AtrophyGastric HistologyGastric PathologyGastrointestinal Mucosa
Formation of gastric mucosal lesions by streptozotocin-induced diabetes was investigated in rats. A single intravenous administration of streptozotocin in a dose of 65 mg/kg effectively produced hyperglycemia and damaged the gastric mucosa. Incidence and severity of mucosal lesions were progressively increased with time, from one to six weeks posttreatment. Microscopic lesions of the mucosa included hyperemia, desquamation of the surface epithelium with diffuse hemorrhage, and severe hemorrhage with localized erosion. Concurrent to the hyperglycemia, the histamine stimulated gastric H+-secretion was significantly decreased whereas pepsin secretion was not affected. Both soluble mucus and surface mucus gel were increased. The result suggests that the early lesion of gastric mucosa may be associated with the direct action of streptozotocin, the severity of which may be further aggravated by diabetic state.
7
Gastric Emptying in Patients With Diabetes Mellitus
Franklin D. Loo, David Palmer, Konrad H. Soergel et al. · Gastroenterology · 1984 · 244 citations
Clinical antitumor activity and toxicity of streptozotocin (NSC-85998)
P. Schein, M J O'Connell, Johannes Blom et al. · Cancer · 1974 · 190 citations · Full text
Medicine, Oncology, Pharmacology +16
Isolation and characterization of streptozotocin.
Herr Rr, Eble Te, Bergy Me et al. · PubMed · 1998 · 57 citations
VAGAL FUNCTION IN PATIENTS WITH DIABETIC NEUROPATHY
G. Dotevall, Sven Fagerberg, L. Langer et al. · Journal of Internal Medicine · 1972 · 23 citations
Medicine, Endocrinology, Physiology +17